Stratos Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,026
Closed -$247K 737
2023
Q4
$247K Buy
+2,026
New +$226K 0.01% 596
2023
Q3
Sell
-1,828
Closed -$266K 722
2023
Q2
$266K Sell
1,828
-106
-5% -$14.4K 0.02% 539
2023
Q1
$250K Sell
1,934
-12
-0.6% -$1.51K 0.02% 531
2022
Q4
$248K Buy
+1,946
New +$226K 0.02% 509
2022
Q3
Sell
-5,281
Closed -$555K 547
2022
Q2
$555K Buy
5,281
+58
+1% +$6.88K 0.05% 345
2022
Q1
$668K Sell
5,223
-303
-5% -$36.5K 0.05% 333
2021
Q4
$682K Buy
5,526
+178
+3% +$23.3K 0.05% 339
2021
Q3
$760K Sell
5,348
-174
-3% -$25.6K 0.06% 293
2021
Q2
$862K Hold
5,522
0.08% 263
2021
Q1
$858K Buy
5,522
+351
+7% +$54.4K 0.09% 237
2020
Q4
$774K Buy
+5,171
New +$730K 0.11% 190
2019
Q4
Sell
-1,595
Closed -$213K 250
2019
Q3
$213K Buy
+1,595
New +$206K 0.08% 235

Other funds holding ZBH

Stratos Wealth Advisors's ZBH Position: Q1 2024 in Review

Stratos Wealth Advisors sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 2,026 shares — an estimated $247K sold.

Stratos Wealth Advisors first reported a position in ZBH in Q3 2019 and held it in 12 quarters. The position peaked at $862K in Q2 2021. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Stratos Wealth Advisors reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Stratos Wealth Advisors sold 2,026 Zimmer Biomet shares in Q1 2024, an estimated $247K.
  • Stratos Wealth Advisors first reported a position in Zimmer Biomet in Q3 2019 and held it in 12 quarters.
  • Stratos Wealth Advisors's Zimmer Biomet position peaked at $862K in Q2 2021.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Stratos Wealth Advisors's 13F filing for Q1 2024, filed 16 Apr 2024.